Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complete remission following targeted therapy in BRAF V600E: mutant pulmonary lymphangitic carcinomatosis secondary to rectal cancer-a case report.

Journal of medical case reports - 21 May 2026

Dao Thi Thu Trang, Tran Thi Thu Hien, Nguyen Huu Loc, Nguyen Dinh Tung, Quach Thanh Dung, Vu Thi Phuong, Vuong Kim Ngan, Le Vu Duy, Yi Hyeon Gyu, Vu Son Hai

Abstract excerpt

BACKGROUND: Pulmonary lymphangitic carcinomatosis (PLC) secondary to colorectal cancer is an uncommon manifestation, accounting for fewer than 7% of all PLC cases. Because of its nonspecific clinical and radiologic features, it is frequently misdiagnosed as interstitial lung disease or pulmonary infection. The prognosis remains poor, as the majority of patient's progress rapidly to acute respiratory failure...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatal Outcome

Share to Lung Neoplasms

Share to Molecular Targeted Therapy

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Rectal Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 42169194
DOI: 10.1186/s13256-026-06109-5
PMCID: PMC13390139

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complete remission following targeted therapy in BRAF V600E: mutant pulmonary lymphangitic carcinomatosis secondary to rectal cancer-a case report.PMID 42169194Read ↗

Durable response to third-line combination therapy in a metastatic colorectal cancer patient with BRAF V600E mutation: A case report.Semantic proximity Read ↗

Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China.Semantic proximity Read ↗

Pulmonary Lymphangitic Carcinomatosis as the Initial and Only Presentation of Gastric Cancer in a Young Male and Literature ReviewSemantic proximity Read ↗

Post-pulmonary metastasectomy prognosis after curative resection for colorectal cancer.Semantic proximity Read ↗

Management of nonbacterial thrombotic endocarditis (NBTE) in advanced non-small cell lung cancer (NSCLC) patients with driver mutation: two case reports.Semantic proximity Read ↗

BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature.Semantic proximity Read ↗

Postmortem Diagnosis of Pulmonary Tumor Thrombotic Microangiopathy in a Patient with Metastatic NTRK Gene Fusion-Positive Transverse Colon Cancer During Effective Entrectinib TreatmentSemantic proximity Read ↗

Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report.Semantic proximity Read ↗

Conversion Surgery After Encorafenib Plus Cetuximab for Chemorefractory BRAF V600E-mutated Colorectal Cancer With Para-aortic Lymph Node Metastases.Semantic proximity Read ↗

The combination of fruquintinib, raltitrexed and S-1 as a third-line treatment for metastatic colorectal cancer: A case reportSemantic proximity Read ↗

[Primary large cell neuroendocrine carcinoma of pulmonary artery: a case report and literature review].Semantic proximity Read ↗

Histological transformation to signet-ring cell carcinoma in a patient with clinically aggressive poorly differentiated adenocarcinoma of the ascending colon after response to chemotherapy plus cetuximab: a case reportSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.